Results 21 to 30 of about 490,842 (303)

Management of severe neonatal respiratory distress due to vertical transmission of severe acute respiratory syndrome coronavirus 2: a case report

open access: yesJournal of Medical Case Reports, 2022
Background Neonates with severe acute respiratory syndrome coronavirus 2 infection are usually asymptomatic or have mild to moderate symptoms. Acute respiratory distress syndrome due to severe acute respiratory syndrome coronavirus 2 with respiratory ...
Anne C. Verheijen   +7 more
doaj   +1 more source

Respiratory sampling for severe acute respiratory syndrome coronavirus 2: An Overview [PDF]

open access: yesHead & Neck, 2020
AbstractThe novel coronavirus disease 2019 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) and was declared a pandemic in March 2020. A plethora of respiratory sampling methods for SARS‐CoV‐2 viral detection has been used and in the current evolving situation, there is no international consensus on the recommended method ...
See, Anna, Toh, Song Tar
openaire   +2 more sources

Acute pancreatitis associated with severe acute respiratory syndrome coronavirus-2 infection: a case report and review of the literature

open access: yesJournal of Medical Case Reports, 2021
Introduction We report a case of Severe acute respiratory syndrome coronavirus-2 infection with acute pancreatitis as the only presenting symptom. To the best of our knowledge, there are few case reports of the same presentation.
Abdullah S. Eldaly   +3 more
doaj   +1 more source

Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes [PDF]

open access: yesFrontiers in Endocrinology, 2021
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is causing a worldwide epidemic. It spreads very fast and hits people of all ages, especially patients with underlying diseases such as diabetes. In this review, we focus on the influences of diabetes on the outcome of SARS-CoV-2 infection and the involved mechanisms including lung ...
Shiying Shao   +7 more
openaire   +3 more sources

Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2.

open access: yesPLoS ONE, 2022
The outbreak of the coronavirus disease 2019 caused by the severe acute respiratory syndrome coronavirus 2 triggered a global pandemic where control is needed through therapeutic and preventive interventions. This study aims to identify natural compounds
Tomokazu Ohishi   +6 more
doaj   +3 more sources

False-positive detection of IgM anti-severe acute respiratory syndrome coronavirus 2 antibodies in patients with rheumatoid arthritis: Possible effects of IgM or IgG rheumatoid factors on immunochromatographic assay results

open access: yesSAGE Open Medicine, 2022
Objectives: The severe acute respiratory syndrome coronavirus 2 causes coronavirus disease 2019. A serological test is conducted to determine prior infection by severe acute respiratory syndrome coronavirus 2.
Shomi Oka   +6 more
doaj   +1 more source

SARS-CoV-2–related outcomes after surgical procedures on SARS-CoV-2–positive patients in a large, urban, safety net medical center

open access: yesSurgery Open Science, 2021
Background: Beginning on March 16, 2020, nonurgent scheduled operations at a large, urban, safety net medical center were canceled. The purpose of this study was to determine complications associated with severe acute respiratory syndrome coronavirus 2 ...
Rachel E. Sargent, MD   +5 more
doaj   +1 more source

A Comprehensive Review of Severe Acute Respiratory Syndrome Coronavirus 2 [PDF]

open access: yesCureus, 2020
Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), the virus strain that causes coronavirus disease 2019 (COVID-19), was first identified in Wuhan, China in December 2019. It spread to several countries across continents and infected more than one million people within three months. While there is no consensus on the treatment of the disease
Baek, Woong Kee   +3 more
openaire   +2 more sources

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)

open access: yesFuture Journal of Pharmaceutical Sciences, 2022
Background The etiological agent for the coronavirus illness outbreak in 2019–2020 is a novel coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (COVID-19), whereas coronavirus disease pandemic of 2019 (COVID-19) has ...
Soumya Gulab Katre   +6 more
doaj   +1 more source

Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic

open access: yesArchives of Pathology & Laboratory Medicine, 2020
Context.— The novel coronavirus disease 2019 (COVID-19) pandemic is significantly changing methodologic approaches in all branches of the health system. From a forensic point of view, this event is partly changing the manner in which forensic pathologists and all those who work in autopsy services operate, but ...
Aquila, Isabella   +11 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy